Table 1 Baseline characteristics of RSV patients

Male, n (%)

661 (62.2)

521 (61.8)

140 (63.6)

0.618

Age

0.311

 0 ~ < 1year

265 (30.7)

203 (29.7)

62 (34.6)

 1 ~ < 3year

154 (17.9)

126 (18.4)

28 (15.6)

 3 ~ < 6year

396 (45.9)

313 (45.8)

83 (46.4)

 6 ~ 14year

47 (5.5)

41 (6)

6 (3.4)

X.rays, n (%)

893 (84.5)

698 (83)

195 (90.3)

0.008

History of allergies, n (%)

98 (9.3)

86 (10.3)

12 (5.5)

0.028

Congenital heart disease, n (%)

24 (2.3)

20 (2.4)

4 (1.8)

0.801

LOS (Days)

5.6 ± 4.3

5.4 ± 3.8

6.4 ± 5.8

< 0.001

WBC (×10⁹/L)

9.4 ± 4.3

9.2 ± 4.2

10.1 ± 4.8

0.003

Neut (×10⁹/L)

4.6 ± 3.5

4.4 ± 3.4

5.0 ± 3.7

0.021

Lymph (×10⁹/L)

3.9 ± 2.3

3.8 ± 2.2

4.0 ± 2.3

0.18

Hb (g/L)

120.7 ± 10.9

120.8 ± 10.9

120.3 ± 11.0

0.544

RBC (×10¹²/L)

4.5 ± 0.5

4.5 ± 0.5

4.5 ± 0.5

0.976

HCT

0.4 ± 0.0

0.4 ± 0.0

0.4 ± 0.0

0.763

MCV (fl.)

81.8 ± 5.7

81.8 ± 5.6

81.8 ± 6.2

0.933

MCH (pg)

27.1 ± 2.8

27.1 ± 2.9

27.0 ± 2.4

0.611

PLT (×10⁹/L)

316.2 ± 113.9

311.7 ± 112.7

333.4 ± 117.0

0.012

PA (mg/L)

134.2 ± 40.4

136.1 ± 40.0

127.5 ± 41.1

0.013

AST (U/L)

50.7 ± 36.8

51.8 ± 40.3

46.6 ± 18.5

0.087

TP (g/L)

67.5 ± 5.8

67.6 ± 5.8

67.1 ± 5.8

0.194

ALB (g/L)

44.7 ± 4.0

44.7 ± 4.0

44.8 ± 3.9

0.879

BUN (mmol/L)

3.5 ± 1.3

3.5 ± 1.3

3.4 ± 1.3

0.492

CREA (µmol/L)

25.7 ± 7.0

25.8 ± 7.1

25.3 ± 6.4

0.345

CA (mmol/L)

2.4 ± 0.2

2.4 ± 0.2

2.4 ± 0.1

0.413

MG (mmol/L)

0.9 ± 0.2

0.9 ± 0.2

0.9 ± 0.1

0.499

NA (mmol/L)

137.6 ± 2.5

137.7 ± 2.4

137.4 ± 2.6

0.126

CL (mmol/L)

103.9 ± 2.6

103.9 ± 2.5

103.7 ± 2.8

0.339

CRP (mg/L)

4.5 (1.2, 13.7)

4.3 (1.1, 13.3)

5.3 (1.3, 16.7)

0.075

PCT (ng/ml)

0.1 (0.1, 0.2)

0.1 (0.1, 0.2)

0.1 (0.1, 0.3)

0.076

ALT (U/L)

20.0 (15.0, 27.0)

20.0 (16.0, 27.0)

19.0 (14.0, 27.0)

0.236

TBIL (µmol/L)

5.4 (4.0, 7.6)

5.3 (4.0, 7.4)

5.4 (4.3, 8.0)

0.178

IgE (IU/ML)

64.6 (19.5, 175.5)

69.6 (20.4, 199.0)

41.2 (14.1, 109.5)

< 0.001